BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7942809)

  • 1. The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension.
    Lopes AA; Hornbuckle K; James SA; Port FK
    Am J Kidney Dis; 1994 Oct; 24(4):554-60. PubMed ID: 7942809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
    Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure.
    Lopes AA
    Adv Ren Replace Ther; 2004 Jan; 11(1):14-23. PubMed ID: 14730535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The excess risk of treated end-stage renal disease in blacks in the United States.
    Lopes AA; Port FK; James SA; Agodoa L
    J Am Soc Nephrol; 1993 Jun; 3(12):1961-71. PubMed ID: 8338929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.
    Li S; McAlpine DD; Liu J; Li S; Collins AJ
    Adv Ren Replace Ther; 2004 Jan; 11(1):5-13. PubMed ID: 14730534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.
    Hsu CY; Lin F; Vittinghoff E; Shlipak MG
    J Am Soc Nephrol; 2003 Nov; 14(11):2902-7. PubMed ID: 14569100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.
    Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of end stage renal disease among low-income blacks and whites.
    Lipworth L; Mumma MT; Cavanaugh KL; Edwards TL; Ikizler TA; Tarone RE; McLaughlin JK; Blot WJ
    PLoS One; 2012; 7(10):e48407. PubMed ID: 23110237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: results from the 1997 ESRD Core Indicators Project. National ESRD Core Indicators Workgroup.
    Rocco MV; Frankenfield DL; Frederick PR; Pugh J; McClellan WM; Owen WF
    Perit Dial Int; 2000; 20(3):328-35. PubMed ID: 10898051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality of blacks and whites with end-stage renal disease attributed to hypertension.
    Am J Kidney Dis; 1992 Nov; 20(5 Suppl 2):27-31. PubMed ID: 1442772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for incident stroke among patients with end-stage renal disease.
    Seliger SL; Gillen DL; Tirschwell D; Wasse H; Kestenbaum BR; Stehman-Breen CO
    J Am Soc Nephrol; 2003 Oct; 14(10):2623-31. PubMed ID: 14514741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and ethnic differences in trends of end-stage renal disease: United States, 1995 to 2005.
    Burrows NR; Li Y; Williams DE
    Adv Chronic Kidney Dis; 2008 Apr; 15(2):147-52. PubMed ID: 18334239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
    Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing patterns of end-stage renal disease due to hypertension.
    Qualheim RE; Rostand SG; Kirk KA; Rutsky EA; Luke RG
    Am J Kidney Dis; 1991 Sep; 18(3):336-43. PubMed ID: 1882825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-stage renal disease in US minority groups.
    Feldman HI; Klag MJ; Chiapella AP; Whelton PK
    Am J Kidney Dis; 1992 May; 19(5):397-410. PubMed ID: 1585925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, end-stage renal disease, and survival in an elderly cohort with cardiovascular disease.
    Lea JP; Crenshaw DO; Onufrak SJ; Newsome BB; McClellan WM
    Obesity (Silver Spring); 2009 Dec; 17(12):2216-22. PubMed ID: 19325542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race, socioeconomic status, and the development of end-stage renal disease.
    Byrne C; Nedelman J; Luke RG
    Am J Kidney Dis; 1994 Jan; 23(1):16-22. PubMed ID: 8285192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.